Enkephalins, Brain and Immunity: Modulation of Immune Responses by Methionine-Enkephalin Injected Into the Cerebral Cavity

References

• Ablin R. J., Bhatti R. A., Guinan P. D., Khin W. Modulatory effects of oestrc gen on immunological responsiveness. Clinical and Experimental Immunology 1979; 38: 83–91
   PubMedGoogle Scholar
• Akil H., Madden J., Patrick R. L., Barchas J. D. Stress induced increase in endogenous opioid peptides: Concurrent analgesia and its partial reversal by naloxone. Opiates and endogenous opioid peptides, H. W. Kosterlitz. Elsevier, Amsterdam 1976; 63–70
   Google Scholar
• Almay B. G. L., Johannson F., Von Knorring L., Terenius L., Wahlstrom A. Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Psychopharmacology 1978; 67: 139–142
   Google Scholar
• Amir S., Van Ree J. M. Beneficial effect of -γ-endorphin-type peptides in anaphylactic shock. Brain Research 1985; 329: 329–333
   PubMedGoogle Scholar
• Atweh S. F., Kuhar M. J. Distribution and physiological significance of opioid receptors in the brain. British Medical Bulletin 1983; 39: 47–52
   PubMed Web of Science ®Google Scholar
• Audigier Y., Attali B., Mazarguli H., Cros J. Characterization of (3H)-etorphine binding in guinea-pig striatum after blocadc of mu and delta sites. Life Sciences 1982; 31: 1287–1290
   PubMedGoogle Scholar
• Baciu I., Olteanu A., Prodan T., Baiescu M., Vaida A. Changes of phagocytic biological rhythm by reduction of circadian times and by influences upon hypothalamus. International Journal of Neuroscience 1988; 41: 143–153
   PubMed Web of Science ®Google Scholar
• Banet S., Brandt S., Hensel H. H. The effect of continuously cooling the hypothalamic preoptic area on antibody titre in the rat. Experientia 1982; 38: 965–966
   PubMedGoogle Scholar
• Banks W. A., Kastin A. J. Saturable transport of peptides across the blood-brain barrier. Life Sciences 1987; 41: 1319–1338
   PubMed Web of Science ®Google Scholar
• Banks W. A., Kastin A. J. Peptides and the blood-brain barrier: penetration and modulating influences. Peptide and amino acid transport mechanisms in the central nervous system, L. Rakic, D. J. Begley, H. Davson, B. V. Zlokovic. Macmillan Press, London 1988; 21–33
   Google Scholar
• Begley D. J., Chain D. G. Clearance of (3H-Tyr)-leucine enkephalin from rabbit cerebrospinal fluid. Journal of Physiology 1981; 319: 40P–41P
   Google Scholar
• Begley D. J., Chain D. G. Transport of neuropeptides from the cerebrospinal fluid of the rabbit. Peptide and amino acid transport mechanisms in the central nervous system, L. Rakic, D. J. Begley, H. Davson, B. V. Zlokovic. Macmillan Press, London 1988; 81–91
   Google Scholar
• Belluzi J. D., Grant N., Garsky V., Sarantakis D., Wise C. D., Stern L. Analgesia induced in vivo by central injection of enkephalin in rat. Nature 1976; 260: 625–626
   PubMedGoogle Scholar
• Bergland R. M., Page R. B. Pituitary-brain vascular relations: a new paradigm. Science 1979; 204: 18–24
   PubMedGoogle Scholar
• Besedovsky H. O., DelRey A., Sorkin E., DaPrada M. The immune response evokes changes in noradrenergic neurons. Science 1983; 221: 564–566
   PubMed Web of Science ®Google Scholar
• Besedovsky H. O., DelRey A., Sorkin E., DaPrada M., Keller H. H. Immunoregulation mediated by the sympathetic nervous system. Cellular Immunology 1979; 48: 346–355
   PubMed Web of Science ®Google Scholar
• Besredka A. Anaphylaxis and anti-anaphylaxis and their experimental foundations. Mosby, St Louis 1919
   Google Scholar
• Blalock J. E., Smith E. M. A complete regulatory loop between the immune and neuroendocrine system. Federation Proceedings 1985; 44: 108–111
   PubMedGoogle Scholar
• Blecha F., Kelley K. W., Satterlee D. G. Adrenal involvement in the expression of delayed-type hypersensitivity to SRBC and contact sensitivity to DNFB in stressed mice. (41339). Proceedings of the Society for Experimental Biology and Medicine 1982; 169: 247–252
   PubMedGoogle Scholar
• Boogaerts M. A., Vermylen J., Deckmyn H., Roelant C., Verwilghen R. L., Jacob H. S., Molodow C. F. Enkephalins modify granulocyte-endothel interactions by stimulating prostacyclin production. Thrombosis and Haemostasis 1983; 50: 572–576
   PubMedGoogle Scholar
• Bowen W. P., Gentleman S., Horkenham M., Pert C. B. Interconverting mu and delta forms of the opiate receptor in rat striatal patches. Proceedings of the National Academy of Sciences USA 1981; 78: 4818–4822
   PubMed Web of Science ®Google Scholar
• Brown D. R., Goldberg L. J. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 1985; 24: 181–191
   PubMed Web of Science ®Google Scholar
• Brown S. L., Van Epps D. E. Suppression of T lymphocyte chemotactic factor production by the opioid peptides-endorphin and met-enkephalin. Journal of Immunology 1985; 134: 3384–3390
   PubMed Web of Science ®Google Scholar
• Brown S. L., Van Epps D. E. Opioid peptides modulate production of interferon by human mononuclear cells. Cellular Immunology 1986; 103: 19–26
   PubMedGoogle Scholar
• Bruni J. F., Van Vugt D. A., Marshall S., Meites J. Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sciences 1977; 21: 461–466
   PubMed Web of Science ®Google Scholar
• Buckingham J. C., Hodges J. R. Opioids and hypothalamo-pituitary-adrenocorticotrophic activity in the rat. Journal of Physiology 1979; 295: 70P
   Google Scholar
• Bulloch K., Moore R. Y. Innervation of the thymus by brain stem and spinal cord in mouse and rat. American Journal of Anatomy 1981; 162: 157–166
   PubMedGoogle Scholar
• Carr D. J. J., Kim C.-H., DeCosta B., Jacobson A. E., Rice K. C., Blalock J. E. Evidence for a 5-class opioid receptor on cells of the immune system. Cellular Immunology 1988; 116: 44–51
   PubMed Web of Science ®Google Scholar
• Casale J. B., Bowman S., Kaliner H. Induction of human cutaneous mast-cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and non-opiate receptor participation. Journal of Allergy and Clinical Immunology 1984; 73: 775–781
   PubMed Web of Science ®Google Scholar
• Civelli O., Machida C., Bunzow J., Albert P., Hanneman H., Salon J., Bidlack J., Grandy G. The next frontier in the molecular biology of the opioid system. The opioid receptors. Molecular Neurobiology 1987; 1: 373–391
   PubMedGoogle Scholar
• Clement-Jones V., Lowry P. J., McLoughlin L., Besser G. M. Acupunture in heroin addicts: changes in met-enkephalin and β-endorphin in blood and cerebrospinal fluid. Lancet 1979; 2: 380–382
   PubMed Web of Science ®Google Scholar
• Cornford E. M., Brown L. D., Crane P. D., Oldendorf W. H. Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 1978; 103: 1297–1303
   PubMed Web of Science ®Google Scholar
• Cross B. A., Kitay G. I. Unit activity in diencephalic islands. Experimental Neurology 1967; 19: 316–360
   PubMedGoogle Scholar
• Cross R. S., Markesberry W. R., Brooks W. H., Roszman T. L. Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response. Brain Research 1985; 196: 79–88
   Google Scholar
• Davson H. The blood-brain barrier. The structure and function of nervous tissue, G. H. Boume. Academic Press, New York 1972; 321–445
   Google Scholar
• DeCohen J. L., Humblet C., Koch M. J. H. Theoretical conformational analysis of met-enkephalin. FEBS Letters 1977; 73: 370–381
   Google Scholar
• Dewey W. L., Bowman E., Jones D., Kachur J., Rosemond R., Welch S., Martin B. R. The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species. Life Sciences 1982; 31: 1741–1743
   PubMedGoogle Scholar
• Domer F. R., Sankar R., Cole S., Wellmeyer D. Dose-dependent amphtemine induced changes in the permeability of the blood-brain barrier in normotensive and spontaneously hypersensitive rats. Experimental Neurology 1980; 70: 576–585
   PubMedGoogle Scholar
• Donahoe R. M., Madden J. J., Hoi lings worth F., Schaffer D., Falek A. Morphine depression of T cell E resetting: Definition of the process. Federation Proceedings 1985; 44: 95–99
   PubMedGoogle Scholar
• Dougherty F. Effect of hormones on lymphatic tissue. Physiological Reviews 1952; 32: 379–401
   PubMed Web of Science ®Google Scholar
• Dyer S. H., Slaughter C. A., Orth K., Moomaw C. R., Hersh L. Comparison of the soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopep-tidases from rat. Journal of Neurochemistry 1990; 54: 547–554
   PubMed Web of Science ®Google Scholar
• Edvinsson L., Nielsen K. C., Owman C. H., West K. A. Alterations in the intracranial pressure, blood-brain barrier, and brain edema after sub-chronic implantation of a cannula into the brain of conscious animals. Acta Physiologica Scandinavica 1971; 82: 527–531
   PubMedGoogle Scholar
• Elde R., Hokfelt T., Johansson O., Terenius L. Immunohistochemical studies using antibodies to leucine-enkephalin. Initial observations on the nervous system of the rat. Neurosci-ence 1976; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Ermish A., Landgraf L., Brust P., Kretzchmar R., Hess J. Peptide receptors of the cerebral capillary endothelium and the transport of amino-acids across the blood-brain barrier. Peptide and amino acid transport mechanisms in the central nervous system, L. Rakic, D. J. Begley, H. Davson, B. V. Zlokovic. Macmillan Press, London 1988; 41–45
   Google Scholar
• Evans C. J., Erdelyi E., Barchas J. D. Candidate opioid peptides for interaction with the immune system. Enkephalins and endorphins. Stress and the immune system, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 3–15
   Google Scholar
• Falke N. E., Fischer E. G. Cell shape of polymorphonuclear leukocytes is influenced by opioids. Immunology 1985; 169: 532–539
   Google Scholar
• Fanselow M. S., Calcagnetti D. J., Helmstetter F. J. Peripheral versus intracerebroventri-cular administration of quaternary naltrexone and the enhancement of Pavlovian conditioning. Brain Research 1988; 444: 147–152
   PubMed Web of Science ®Google Scholar
• Farrar W. L., Hill J. M., Harel-Belan A., Vinocour M. The immune logical brain. Immunological Reviews 1987; 100: 361–378
   PubMed Web of Science ®Google Scholar
• Feldberg W., Sherwood S. L. A permanent cannula for intraventricular injections in cats. Journal of Physiology 1953; 120: 3p–5p
   Google Scholar
• Feldberg W., Wei E. Central sites at which morphine acts when producing cardiovascular effects. Journal of Physiology 1977; 275: 57
   Google Scholar
• Felten D. L., Felten S. Y., Carlson S. L., Oschowka J. A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. Journal of Immunology 1985; 135: 755s–765s, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Feuerstein G., Powell E., Fadden A. I. Central effects of mu, delta and kappa receptor agonists in hemorrhagic shock. Peptides 1985; 6((Suppl. 1))11–13
   PubMedGoogle Scholar
• Feuerstein G. The opioid system and central cardiovascular control: analysis of controversies. Peptides 1985; 6((Suppl. 2))51–56
   PubMedGoogle Scholar
• Fiorica E., Spector S. Opioid binding site in EL-4 thymoma cell line. Life Sciences 1988; 42: 199
   PubMedGoogle Scholar
• Firemark H., Brand N. Enkephalin transport by chorioid plexus. Clinical Research 1979; 27: 52A
   Google Scholar
• Foris G., Medgyesi G. A., Szekely J. I. Bidirectional effect of met-enkephalin on macrophage effector functions. Molecular Immunology 1986; 21: 747–750
   Google Scholar
• Fu T.-C., Dewey W. L. Morphine antinociception: evidence for release of endogenous sub-stance(s). Life Sciences 1979; 25: 53–60
   PubMedGoogle Scholar
• Funke I., Hahn A., Rieber E. P., Weiss E., Reithmuller G. The cellular receptor (CD4) of the human immunodeficiency virus expressed on neurons and glial cells in human brain. Journal of Experimental Medicine 1987; 165: 1230–1235
   PubMed Web of Science ®Google Scholar
• Gausas J., Paterson P. Y., Day E. D., Dal Canto M. C. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cellular Immunology 1982; 72: 360–366
   PubMed Web of Science ®Google Scholar
• Ghali W. M., Abdel-Rahman S., Nagib M., Mahran Z. Y. Intrinsic innervation and vasculature of pre-and post-natal human thymus. Acta Anatomica 1980; 108: 115–123
   PubMedGoogle Scholar
• Gisler R. H., Schenkel-Hulliger L. Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cellular Immunology 1971; 2: 646–657
   PubMedGoogle Scholar
• Gmerek D. E., Katz J. L., France C. P., Woods J. H. Systemic and intracerebroventncular effects of opioid peptides in withdrawn morphine-dependent rhesus-monkeys. Life Sciences 1983; 33: 361–364, (Suppl.)
   PubMedGoogle Scholar
• Goetzl E. J., Chernov T., Renold F., Payan D. G. Neuropeptide regulation of the expression of immediate hypersensitivity. Journal of Immunology 1985; 135: 802s–805s, (Suppl.)
   Web of Science ®Google Scholar
• Goodman R. R., Snyder S. H., Kuhar M. J., Young S. W., III. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proceedings of the National Academy of Sciences USA 1980; 77: 6239–6243
   PubMed Web of Science ®Google Scholar
• Gorman S. D., Tourvieille B., Parnes J. R. Structure of the mouse gene encoding CD4 and an unusual transcript in brain. Proceedings of the National Academy of Sciences USA 1987; 84: 3526–3530
   PubMedGoogle Scholar
• Gosnel B. A., Levine A. S., Morley J. E. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sciences 1986; 38: 1081–1088
   PubMedGoogle Scholar
• Gudelsky G. A., Porter J. C. Morphine-and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neurons. Life Sciences 1979; 25: 1697–1701
   PubMed Web of Science ®Google Scholar
• Hall N. R., McGillis J. P., Spangelo B. L., Goldstein A. L. Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmitters. Journal of Immunology 1985; 135: 806s–811s, (Suppl.)
   PubMedGoogle Scholar
• Hansen P. E., Morgan B. A. Structure-activity relationships in enkephalin peptides. The peptides: analysis, synthesis and biology, S. Udenfriend, J. Meienhofer. Academic Press, Orlando 1984; vol. 6: 269–321
   Google Scholar
• Happ M. P., Heber-Katz E. Differences in the repertoire of the Lewis rat T-cell response to self and non-self myelin basic proteins. Journal of Experimental Medicine 1988; 167: 502–513
   PubMedGoogle Scholar
• Hassen A. H., Feuerstein G., Faden A. I. Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei. Peptides 1983; 4: 621–625
   PubMed Web of Science ®Google Scholar
• Hazum E., Chang K. J., Cuatrecasas P. C. Specific nonopioid receptors for β-endorphin. Nature 1979; 205: 1033–1035
   Google Scholar
• Hedner T., Cassuto J. Opioids and opioid receptors in peripheral tissues. Scandinavian Journal of Gastroenterology 1987; 130: 27–46
   Google Scholar
• Herz A., Millan M. J. Opioid peptides in the hypothalamic-pituitary axis. Opioids: past, present, and future, J. Hughes, H. O.J. Collier, M. J. Ranee, M. B. Tyers. Taylor & Francis, London and Philadelphia 1984; 79–102
   Google Scholar
• Hokfelt T., Jungdahl A., Terenius L., Elde R., Nilsson G. Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proceedings of the National Academy of Sciences USA 1977; 74: 3081–3085
   PubMed Web of Science ®Google Scholar
• Holaday J. W. Cardiovascular consequences of endogenous opiate antagonism. Biochemical Pharmacology 1983; 32: 573–585
   PubMed Web of Science ®Google Scholar
• Holaday J. W., D'Amato R. J. Multiple opioid receptors: Evidence for μ.-dL binding site interactions in endotoxic shock. Life Sciences 1983; 33: 703–706, (Suppl.)
   PubMedGoogle Scholar
• Hudgin R. L., Charleson S. E., Zimmerman M., Mumfold R., Wood P. L. Enkephalinase: selective peptide inhibitors. Life Sciences 1981; 29: 2593–2601
   PubMed Web of Science ®Google Scholar
• Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975; 258: 577–579
   PubMed Web of Science ®Google Scholar
• Hughes J. Biogenesis, release and inactivation of enkephalins and dynorphins. British Medical Bulletin 1983; 39: 17–24
   PubMedGoogle Scholar
• Hyppa M. T., Lira J., Skett P., Gustafsson J. A. Neuropeptide hormones in cerebrospinal fluid: Experimental and clinical aspects. Medical Biology 1979; 57: 367–373
   PubMedGoogle Scholar
• Jankovi B. D. Biological activity of antibrain antibody: An introduction to imunoneurology. Macromolecules and behavior, J. Gaito. Appleton-Century-Crofts, New York 1972; 99–130
   Google Scholar
• Jankovi B. D. Structural correlates of immune microenvironment. Microenvironmental aspects of immunity, B. D. Jankovic, K. Isakovi. Plenum Press, New York 1973; 1–4
   Google Scholar
• Jankovi B. D. From neuroimmunology to neuropsychiatry: neuromodulating activity of anti-brain antibodies. International Review of Neurobiology 1985; 26: 249–314
   PubMedGoogle Scholar
• Jankovi B. D. Neuroimmune interactions: experimental and clinical aspects. Lmmunolog\ Letters 1987; 16: 341–354
   PubMedGoogle Scholar
• Jankovi B. D. Neuroimmunomodulation: Facts and dilemmas. Immunology Letters 1989; 21: 101–118
   PubMedGoogle Scholar
• Jankovi B. D. Enkephalins and immune inflammatory reactions. Acta Neurologica 1991; 13: 433–441
   PubMedGoogle Scholar
• Jankovi B. D., Drakoci M., Isakovi K. Antibody response in rabbits following injection of sheep erytrocytes into lateral ventricle of brain. Nature 1961; 191: 288–289
   Google Scholar
• Jankovi B. D., Isakovi K. Neuro-endocrine correlation of immune response. I. Effects of brain lesions on antibody production, Arthus reactivity and delayed hypersensitivity in the rat. International Archives of Allergy and Applied Immunology 1973; 45: 360–372
   PubMedGoogle Scholar
• Jankovi B. D., Jovanova-Nei K., Markovi B. M. Neuroimmunomodulation: Potentiation of delayed hypersensitivity and antibody production by chronic electrical stimulation of the rat brain. International Journal of Neuroscience 1988; 39: 153–164
   PubMed Web of Science ®Google Scholar
• Jankovi B. D., Mari D. Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Annals of the New York Academy of Sciences 1987a; 496: 115–125
   PubMedGoogle Scholar
• Jankovi B. D., Mari D. Enkephalins and anaphylactic shock: modulation and prevention of shock in the rat. Immunology Letters 1987b; 15: 153–160
   PubMedGoogle Scholar
• Jankovi B. D., Mari D. Enkephalins and autoimmunity: Differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats. Journal of Neuroscience Research 1987c; 18: 88–94
   PubMedGoogle Scholar
• Jankovi B. D., Mari D. Enkephalins modulate in vivo immune reactions through delta-and mu-opioid receptors. Annals of the New York Academy of Sciences 1988; 540: 691–693
   PubMedGoogle Scholar
• Jankovi B. D., Mari D., Velji J. Cerebrally mediated modulation of anaphylactic shock by methionine-enkephalin. International Journal of Neuroscience 1990; 51: 193–194
   PubMedGoogle Scholar
• Neuroimmune interactions, B. D. Jankovi, B. M. Markovi, N. H. Spector. The New York Academy of Sciences, New York 1987
   Google Scholar
• Jankovi B. D., Raki L., Veskov R., Horvat J. Anaphylactic reaction in the cat following intraventricular and intravenous injections of antigens. Experientia 1969; 25: 864–865
   PubMedGoogle Scholar
• Jankovi B. D., Velji J., Pei G., Mari D. Enkephalinase-inhibitors modulate immune responses. International Journal of Neuroscience 1991; 59: 45–51
   PubMedGoogle Scholar
• Johnson H. M., Smith E. M., Torres B. A., Blalock J. E. Regulation of the in vitro antibody response by neuroendocrine hormones. Proceedings of the National Academy of Sciences USA 1982; 79: 4171–4174
   PubMed Web of Science ®Google Scholar
• Kalra S. P., Simpkins J. W. Evidence for noradrenergic mediation of opioid effects on luteinizing hormone secretion. Endocrinology 1981; 109: 776–782
   PubMed Web of Science ®Google Scholar
• Karpus W. J., Kronkol R. J., Killen J. A. Central catecholamine neurotoxin administration. I. Immunological changes associated with suppression of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 1988; 18: 61–73
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Olson R. D., Schally A. V., Coy D. H. Blood-brain barrier, half-time dis-sapearance, and brain distribution of labelled enkephalin and a potent analogue. Brain Research Bulletin 1976; 1: 583–589
   PubMedGoogle Scholar
• Kastin A. J., Olson R. D., Schally A. V., Coy D. H. CNS effects of peripherally administered peptides. Life Sciences 1984; 25: 401–414
   Google Scholar
• Keller S. E., Weiss J. M., Schleifer S. J., Miller N., Stein M. Stress-induced suppression of immunity in adrenalectomized rats. Science 1983; 221: 1301–1303
   PubMed Web of Science ®Google Scholar
• Komeva E. A., Khay L. M. Influence of hypothalamic part destruction on the immunogenesis process (in Russian). Physiological Journal USSR 1963; 49: 42–48
   PubMedGoogle Scholar
• Krueger J., Dinarello C., Wolff M., Chedid L., Walter J. Sleep-promoting effects of endogenous pyrogen (interleukin-1). American Journal of Physiology 1984; 246: R994
   PubMed Web of Science ®Google Scholar
• Lang R. E., Bruckner U. B., Hermann K., Kempf B., Raschcr W., Sturm V., Ganten D. Effect of hemorrhagic shock on the concomitant release of endorphin and enkephalin-like peptides from the pituitary and adrenal gland in the dog. Advances in Biochemical Psychopharmacology 1982; 33: 363–368
   PubMedGoogle Scholar
• Lang R. E., Bruckner U. B., Kempf B., Rascher W., Sturm V., Unger T., Speck G., Ganten D. Opioid peptides and blood pressure regulation. Clinical and Experimental Hypertension, (A) 1982; (1–2): 249–269
   Google Scholar
• Lennon V. A., Byrd W. J. Role of T-lymphocytes in the pathogenesis of experimental autoimmune encephalomyelitis. European Journal of Immunology 1973; 3: 243–245
   PubMed Web of Science ®Google Scholar
• Levine J. D., Clark R., Devor M., Helms C., Moskowitz M. A., Basbaum A. I. Intra-neuronal substance P contributes to the severity of experimental arthritis. Science 1984; 226: 547–549
   PubMed Web of Science ®Google Scholar
• Lewis J. W., Tordoff M. G., Sherman J. E., Liebeskind J. C. Adrenal enkephalin-like peptides may mediate opioid stress analgesia. Science 1982; 217: 557–559
   PubMed Web of Science ®Google Scholar
• Lloyd R. Mechanisms of psychoneuroimmunological response. Impact of psychoneuroendocrine systems in cancer and immunity, B. S. Fox, B. H. Newberry. C. J. Hogrefe, Inc., Lewiston 1983; 1–57
   Google Scholar
• Long G. B., Holaday J. W. Blood-brain barrier: Endogenous modulation by adrenal cortical function. Science 1985; 227: 1580–1583
   PubMedGoogle Scholar
• Lopker A., Abood L. G., Hoss W., Lionetti F. J. Stereoselective muscarinic, acetylcholine and opiate receptors in human phagocytic leukocytes. Biochemical Pharmacology 1980; 29: 1361–1365
   PubMed Web of Science ®Google Scholar
• Luparello T. J., Stein M., Park C. D. Effects of hypothalamic lesions on rat anaphylaxis. American Journal of Physiology 1964; 207: 911–914
   PubMed Web of Science ®Google Scholar
• Madden J., Akil H., Patrick R. L., Barchas J. D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature 1977; 265: 358–360
   PubMed Web of Science ®Google Scholar
• Malfroy B., Swerts J. P., Guyan A. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978; 276: 523–526
   PubMed Web of Science ®Google Scholar
• Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Autoradiographic differentiation of mu, delta and kapa opioid receptors in the rat forebrain and midbrain. Journal of Neuroscience 1987; 7: 2445–2464
   PubMed Web of Science ®Google Scholar
• Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends in Neurosciences 1988; 11: 308–314
   PubMed Web of Science ®Google Scholar
• Mari D., Jankovi B. D. Enkephalins and immunity. II. In vivo modulation of cell-mediated immunity. Annals of the New York Academy of Sciences 1987; 496: 126–136
   PubMedGoogle Scholar
• Martin R., Voigt K. H. Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis. Nature 1981; 289: 502–504
   PubMedGoogle Scholar
• Martin R., Geis R., Holl R., Schaffer M., Voigt K. H. Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophysis: Immunoreactive methionine-enkephalin-, leucine-enkephalin-, and cholecystokinin-like substances. Neuroscience 1983; 8: 213
   PubMedGoogle Scholar
• Martinez J. L., De Graaf J. S., Chavkin C., Dana R. C. Leu-enkephalin actions on avoidance conditioning are mediated by a peripheral opioid mechanism. Life Sciences 1985; 37: 2345–2353
   PubMed Web of Science ®Google Scholar
• Mathews P. M., Froelich C. J., Sibbit W. L., Bankhurst A. D. Enhancement of natural cytotoxicity by beta-endorphin. Journal of Immunology 1983; 130: 1658–1662
   PubMed Web of Science ®Google Scholar
• McGillis J. P., Hall N. R., Vahouny G. V., Goldstein A. L. Thymosin fraction 5 causes increased serum corticosterone in rodents in vivo. Journal of Immunology 1985; 134: 3952–3955
   PubMedGoogle Scholar
• McKnight A. T., Corbett A. D., Kosterlitz H. W. Increase in potencies of opioid peptides after peptidase inhibition. European Journal of Pharmacology 1983; 86: 393–402
   PubMed Web of Science ®Google Scholar
• McPhah L. C., Snyderman R. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractant and other soluble stimuli. Journal of Clinical Investigations 1983; 72: 192–195
   PubMedGoogle Scholar
• Munson P. L. Effects of morphine and related drugs on the corticotropin (ACTH)-stress reaction. Programmed Brain Research 1973; 39: 361–372
   PubMedGoogle Scholar
• Murphy L. R., Glick S. D., Almenoff J., Wilk S., Orlowski M. Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: analgesic properties and effects on striatal enkephalin levels. European Journal of Pharmacology 1984; 102: 305–313
   PubMedGoogle Scholar
• Myers R. D. Blood-brain barrier: Technique for the intracerebral administration of drugs. Handbook of psychopharmacology, I. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1975; 1–28
   Google Scholar
• Naranjo J. R., Sanchez-Francs F., Garzon J., Del Rio J. Analgesic activity of substance P: apparent mediation by met-enkephalin release. Life Sciences 1982; 30: 441–446
   PubMedGoogle Scholar
• Ng L., Dionne R., Bragin E., Pert C. B., Pert A. Alterations in rat central nervous system endorphins following transauricular electroacupuncture. Abstracts of the Society for Neurosciences 1980; 6: 35
   Google Scholar
• North R. A., Egan T. M. Actions and distributions of opioid peptides in peripheral tissues. British Medical Bulletin 1983; 39: 71–75
   PubMed Web of Science ®Google Scholar
• North R. A., Williams J. T., Surprenant A., Christie M. J. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proceedings of the National Academy of Sciences USA 1987; 84: 5487–5491
   PubMed Web of Science ®Google Scholar
• Ovadia H., Nitsan P., Abramsky O. Characterization of opiate binding sites on membranes of rat lymphocytes. Journal of Neuroimmunology 1989; 21: 93–102
   PubMed Web of Science ®Google Scholar
• Palkovits M. Topography of chemically identified neurons in the sentral nervous system: A review. Acta Morphologica Academiae Scientiorum Hungaricae 1978; 26: 211–290
   PubMedGoogle Scholar
• Pardridge W. M., Meitus L. J. Enkephalin and blood-brain barrier: studies of binding and degradation in isolated brain microvessels. Endocrinology 1981; 109: 1138–1143
   PubMedGoogle Scholar
• Pardridge W. M. Neuropeptides and the blood-brain barrier. Annual Review of Physiology 1983; 45: 73–82
   PubMed Web of Science ®Google Scholar
• Pardridge W. M. Mechanisms of neuropeptide interactions with the blood-brain barrier. Annals of the New York Academy of Sciences 1986; 481: 231–249
   PubMedGoogle Scholar
• Paterson S. J., Robson L. E., Kosterlitz H. W. Opioid receptors. The peptides: analysis, synthesis and biology, S. Udenfriend, J. Meienhofer. Academic Press, Orlando 1984; Vol. 6: 147–189
   Google Scholar
• Payan D. G., Levine J. D., Goetzl E. J. Modulation of immunity and hypersensitivity by sensory neuropeptides. Journal of Immunology 1984; 132: 1601–1604
   PubMed Web of Science ®Google Scholar
• Payan D. G., Goetzl E. J. Modulation of lymphocyte function by sensory neuropeptides. Journal of Immunology 1985; 135: 783s–786s, (Suppl)
   Web of Science ®Google Scholar
• Perlow M. J., Reppert S. M., Artman H. G., Fischer D. A., Seif S. M., Robinson A. G. Oxytocin, vasopresin and estrogen-mediated neurophysin: daily patterns of concentrations in cerebrospinal fluid. Science 1982; 216: 1416–1418
   PubMedGoogle Scholar
• Petty M. A., De Jong W. Cardiovascular effects of β-endorphin after microinjection into the nucleus tractus solitarii of the anesthetized rat. European Journal of Pharmacology 1982; 81: 449–457
   PubMed Web of Science ®Google Scholar
• Petty M. A., De Jong W., De Wied D. The blood pressure changes resulting from the microinjection of fragments of the beta endorphin molecule into the nucleus tractus slitarii (NTS). Life Sciences 1983; 33((Suppl. 1))735–737
   PubMedGoogle Scholar
• Pfeifer A., Feuerstein G., Kopin I. J., Faden A. I. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamus brain area of awake rats. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 735–741
   PubMedGoogle Scholar
• Pfeifer A., Feuerstein G., Zerbe R. L., Faden A. I., Kopin I. J. u.-receptors mediate cardiovascular effects at anterior hypothalamic sites through sympathoadrenomedullary and parasympathetic pathways. Endocrinology 1983; 113: 929–938
   PubMedGoogle Scholar
• Plotnikoff N. P., Kastin A. J., Coy D. H., Christensen C. W., Serially A. V., Spines M. A. Neuropharmacological actions of enkephalin after systemic administration. Life Sciences 1976; 19: 1283–1288
   PubMed Web of Science ®Google Scholar
• Plotnikoff N. P., Murgo A. J., Miller G. C., Corder C. N., Faith R. E. Enkephalins: immunomodulators. Federation Proceedings 1985; 44: 118–122
   PubMedGoogle Scholar
• Poplack D. G., Bleyer W. A., Horowitz M. E. Pharmacology of antineoplastic agents in cerebrospinal fluid. Neurobiology of the cerebrospinal fluid, J. H. Wood. Raven Press, New York 1980; 561–578
   Google Scholar
• Porter J. C., Ben-Jonathan N., Olivier C., Eskay R. L. Secretion of releasing hormones and their transport from CSF to hypophyseal portal blood. Brain-endocrine interaction. II. The ventricular system in neuroendocrine mechanisms, K. M. Knigge, H. Kobayashi, S. Ishii. S. Karger, Basel 1975
   Google Scholar
• Post R. M., Gold P. W., Runibow D. R., Bunney W. E., Jr., Ballenger J. C., Goodwin F. K. Cerebrospinal fluid as neuroregulatory pathway: Peptides in neuropsychiatric illness. Neurobiology of the cerebrospinal fluid, J. H. Wood. Plenum Press, New York 1984; 107–141
   Google Scholar
• Rapoport S. I., Klee W. A., Pettigrew K. D., Ohno K. Entry of opioid peptides into the central nervous system. Science 1980; 207: 84–86
   PubMed Web of Science ®Google Scholar
• Roda L. G., De Marco V., Possenti R. Stability of peripheral enkephalins. Degradation of endogenous opioid, S. Hhrenpreis, F. Sicuteri. Raven Press, New York 1983; 25–42
   Google Scholar
• Roda L. G., Roscetti G., Possenti R., Venturelli F., Vita F. Control mechanisms in the enzyme hydrolysis of adrenal released enkephalins. Enkephalins and endorphins. Stress and the immune system, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 17–33
   Google Scholar
• Rebar R. W., Miyake A., Low T. L. K., Goldstein A. L. Thymosin stimulates secretion of luteinizing hormone-releasing factor. Science 1981; 214: 669–671
   PubMed Web of Science ®Google Scholar
• Roemer D., Buechner H. H., Hill R. C. A synthetic enkephalin analogue with prolonged parenteral and oral activity. Nature 1977; 268: 547–549
   PubMed Web of Science ®Google Scholar
• Roscetti G., Possenti R., Bassano E., Roda L. G. Mechanisms of leu-enkephalin hydrolysis in human blood. Life Sciences 1984; 45: 193–197
   Google Scholar
• Roszman T. L., Cross R. J., Brooks W. H., Markesberry W. R. Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis. Immunology 1982; 45: 737–742
   PubMed Web of Science ®Google Scholar
• Rossier J., Battenberg E., Pittman Q., Bayon A., Koda L., Miller R., Guillemin R., Bloom F. Hypothalamic enkephalin containing neurons may regulate the neurohypophysis. Nature 1979; 277: 653–655
   PubMedGoogle Scholar
• Roth K. A., Lorenz R. G., Unanue R. A., Weaver C. T. Nonopiate active proenkephalin-derived peptides are secreted by T helper cells. FASEB Journal 1989; 3: 2401–2407
   PubMed Web of Science ®Google Scholar
• Same Y., Azov R., Weissman B. A. A stable enkephalin-like immunoreactive substance in human CSF. Brain Research 1978; 151: 399–403
   PubMedGoogle Scholar
• Savino W., Dardenne M. Enkephalin immunohistochemical detection in human thymic epithelial cells. Proceedings of the first international workshop on neuroimmunomodulation, N. H. Spector. IWGN, Bethesda 1984; 55–56
   Google Scholar
• Schiller P. W. Conformational analysis of enkephalin and conformation-activity relationships. The peptides: analysis, synthesis, and biology, S. Udenfriend, J. Meienhofer. Academic Press, Orlando 1984; vol. 6: 219–268
   Google Scholar
• Schluesener H. J., Weckerle H. Autoaggressive T lymphocyte lines recognizing the en-cephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. Journal of Immunology 1985; 135: 3128–3133
   PubMed Web of Science ®Google Scholar
• Schultzberg M., Lundberg J. M., Hokfelt T., Terenius L., Brandt J., Elde R. P., Goldstein M. Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 1978; 3: 1169–1186
   PubMed Web of Science ®Google Scholar
• Shanahan F., Lee T. D. G., Bienenstock J., Befus A. D. The influence of endorphins on peritoneal and mucosal mast cell secretion. Journal of Allergy and Clinical Immunology 1984; 74: 499–504
   PubMed Web of Science ®Google Scholar
• Sharp B. M., McKeane W. F., Suh H. J., Gekker G., Tsukyama D., Peterson D. K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985; 117: 793–795
   PubMed Web of Science ®Google Scholar
• Simantov R., Snyder S. H. Opiate receptor binding in the pituitary gland. Brain Research 1977; 124: 178–184
   PubMedGoogle Scholar
• Smith E. M., Blalock J. E. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proceedings of the National Academy of Sciences USA 1981; 78: 7530–7534
   PubMed Web of Science ®Google Scholar
• Smith G. D., Griffin J. F. Conformation of (Leu5) enkephalin from X-ray diffraction: features important for recognition of opiate receptor. Science 1978; 199: 1214–1216
   PubMed Web of Science ®Google Scholar
• Smith E. M., Harbour-McMenamin D., Blalock J. E. Lymphocyte production of endorphins and endorphin mediated immunoregulatory activity. Journal of Immunology 1985; 135: 779s–782s, (Suppl.)
   Google Scholar
• Smith C. B., Hollingsworth P. J., Geer J. J., Moises H. C. Changes in alpha-2 adreno-receptors in various areas of the rat brain after long-term administration of “mu” and “kappa” opiate agonists. Life Sciences 1983; 33: 369–372, (Suppl.)
   PubMedGoogle Scholar
• Stubbs W. A., Delitalia G., Jones A., Jeffcoate W. J., Edwards C. R. W., Ratter S. J., Besser G. M., Bloom S. R., Alberti K. G.M. M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 1978; 2: 1225–1227
   PubMed Web of Science ®Google Scholar
• Tseng L., Ioh H. H., Li C. H. 0-Endorphin as a potent analgesic by intravenous injection. Nature 1976; 263: 329
   PubMedGoogle Scholar
• Tsokos G. C., Balow J. E. Regulation of human cellular immune responses by glucocorticoids. Enkephalins and endorphins. Stress and the immune system, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 159–171
   Google Scholar
• Udenfriend S., Kilpatrick D. L. Proenkephalin and the products of its processing: Chemistry and Biology. The peptides: analysis, synthesis and biology, S. Udenfriend, J. Meienhofer. Academic Press, Orlando 1984; vol. 6: 25–66
   Google Scholar
• Ukai M., Holtzman S. G. Effects of intrahypothalamic administration of opioid peptides selective for μ-, K-, AND dL-receptors on different schedules of water intake in the rat. Brain Research 1988; 459: 275–281
   PubMedGoogle Scholar
• Van Epps D. E., Saland L. p-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. Journal of Immunology 1984; 132: 3046–3053
   PubMed Web of Science ®Google Scholar
• Van Houten M., Posner B. I. Circum ventricular organs: receptors and mediators of direct peptide hormone action on the brain. Advances in metabolic disorders, A. J. Szabo. Academic Press, New York 1983; 269–290
   Google Scholar
• Van Vugt D. A., Meites J. Influence of endogenous opiates on anterior pituitary function. Federation Proceedings 1980; 39: 2533–2538
   PubMedGoogle Scholar
• Veljic J., Marie D., Jankovic B. D. Effect of intracerebroventricularly injected methionine-enkephalin on humoral immune response in the rat. Periodicum Biologorum 1990; 92: 73–74
   Web of Science ®Google Scholar
• Viveros O. H., Diliberto E. J. J., Hazum E., Chang K. J. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Molecular Pharmacology 1979; 16: 1101–1108
   PubMed Web of Science ®Google Scholar
• Von Möllendorf W. Handbuch der Mikroskopischen Analomie der Menschen Nervensystem. 1. Teil. Springer, Berlin 1928
   Google Scholar
• Weindl A. Neuroendocrine aspects of circumventricular organs. Frontiers in endocrinology, W. F. Ganong, L. Martini. Oxford University Press, London 1973; 1–32
   Google Scholar
• Werdelin O., McCluskey R. T. The nature and specificity of mononuclear cells in experimental autoimmune inflammations and the mechanism leading to their accumulation. Journal of Experimental Medicine 1971; 133: 1242–1263
   PubMed Web of Science ®Google Scholar
• Wertman E., Ovadia H., Feldman S., Abramsky O. Prevention of experimental autoimmune disease by anterior hypothalamic lesion in rats. Neurology 1985; 35: 1468–1470
   PubMed Web of Science ®Google Scholar
• Wiegant V. M., Gispen W. H., Terenius L., De Wied D. ACTH-like peptides and morphine: interaction at the level of CNS. Psychoneuroendocrinology 1977; 2: 63–70
   PubMedGoogle Scholar
• Williams J. M., Peterson R. G., Shea P. A., Schedtje J. F., Bauer D., Felten D. L. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Research Bulletin 1981; 6: 83–84
   PubMed Web of Science ®Google Scholar
• Woloski B. M.R.N.J., Smith E. M., Meyer W. J., III, Fuller G. M., Blalock J. E. Corticotropin-releasing activity of monokines. Science 1985; 230: 1035–1040
   PubMed Web of Science ®Google Scholar
• Wolozin B. L., Pasternak G. W. Classiflcation of multiple morphine and enkephalin binding sites in the central nervous system. Proceedings of National Academy of Sciences (USA) 1981; 78: 6181–6185
   PubMed Web of Science ®Google Scholar
• Wybran J., Appelboom T., Famaey J. P., Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin binding sites on normal human blood T lymphocytes. Journal of Immunology 1979; 123: 1068–1070
   PubMed Web of Science ®Google Scholar
• Wybran J. Enkephalins as modifiers of lymphocyte activation and modifiers of the biological response. Enkephalins and endorhins. Stress and the immune system, N. P. Plotnikoff, R. E. Faith, A. J. Murgo, R. A. Good. Plenum Press, New York 1986; 253–262
   Google Scholar
• Yaksh T. L., Jessel T. M., Gamse R., Mudge A. W., Leeman S. E. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980; 286: 155–157
   PubMed Web of Science ®Google Scholar
• Yamasaki Y., Shimamura O., Kizu A., Nakagawa N., Ijishi H. Interactions of morphine with PGEI, isoproterenol, dopamine and aminophyline in rat mast cells, their effects on IgE mediated 14C-serotonine release. Agent Actions 1983; 13: 21–28
   PubMedGoogle Scholar
• Zurawski G., Benedik M., Kamb B. J., Abrams J. S., Zurawski S. M., Lee F. D. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 1986; 232: 772–775
   PubMed Web of Science ®Google Scholar